Your First GLP-1 Consultation: What to Prepare and Expect
Most people walk into a first GLP-1 consultation thinking it is a sales call. They brace to be sold. Then a clinician asks about their last lab work, their gallbladder, the medications already in the cabinet, and the bracing turns to scrambling. The visit that goes well is the one you packed for. So here is the packing list, plus the one thing nobody tells you to bring.
A first GLP-1 consultation is a clinical review where a licensed physician decides whether a GLP-1 medication is appropriate for you. You share your health history, current medications, and goals. The physician checks for contraindications and may order labs. It is not a guarantee of a prescription, and nothing here replaces your physician's judgment. Individual results vary.
A first consultation is a safety review, not a sales pitch
The physician reviews your medical history, current medications, allergies, family history, and weight history. They screen for conditions that change whether a GLP-1 fits, such as a personal or family history of certain thyroid cancers, pancreatitis, or gallbladder disease. They also ask about pregnancy plans. This is screening, not diagnosis, and only a clinician makes that call.
What to prepare before your first GLP-1 consultation
Recent labs. A1C, kidney and liver panels, and lipids if you have them. If not, the physician may order them.
The questions a physician asks, and the ones you should ask back
A first GLP-1 consultation runs two directions. The physician asks to judge safety and fit. You ask to judge whether the provider is one worth trusting. The strongest visits are the ones where both sets of questions get clear answers. Walk in ready to answer, and ready to ask.
| Question to ask your provider | What a strong answer sounds like | Why it matters |
|---|---|---|
| Who actually prescribes my medication? | A US-licensed physician, named and verifiable | Confirms a real clinician, not an algorithm, owns the decision |
| What does follow-up look like after this? | A set cadence of clinician check-ins, not silence | Follow-up, not the prescription, is where treatment works |
| What are all the costs, every line item? | Medication, any lab, any consult, and cancellation, all disclosed | Hidden fees are the most common patient complaint |
| Is the pharmacy licensed and verifiable? | A state-licensed pharmacy you can look up | Where your medication is prepared is a safety question |
| How do I reach a clinician between visits? | A secure message channel with a real clinician reply | This is the difference between care and a checkout |
Family history. Especially thyroid cancer or endocrine conditions a physician will ask about.
No part of this is a dose you set yourself. Titration, the gradual adjustment of a GLP-1 medication, is always physician-managed. You never increase a dose on your own. Your clinician decides if, when, and how, based on how you respond.
What happens after the consultation
Compounded medicines are not FDA-approved. Ask the prescriber and dispensing pharmacy why a compounded product is being considered, how it differs from an approved product, and what current requirements apply. A patient-specific prescription does not make a compounded medicine FDA-approved. 4.
Do I need lab work before my first GLP-1 consultation? Not always before, but often as part of the process. Many physicians review recent labs or order new ones, such as A1C and kidney and liver panels, before or shortly after the visit. Bring any recent results you have. Your physician decides what is needed.
Walk in prepared, and the visit works for you
A first GLP-1 consultation is not a hurdle. It is the part of the process designed to protect you, and it works best when you arrive ready. Here is how to do that in three steps.
Lose weight with a plan made just for you
- Same-day doctor visits and prescriptions
- Semaglutide, tirzepatide & other GLP-1s
- FSA & HSA eligible with all plans
From price shown is the 12-month plan rate. Prices may vary.
Frequently asked questions
Was this helpful?
Keep reading
Weight Loss
Weight Loss
Weight Loss
Weight Loss
Weight Loss
Weight Loss
Sources
- KFF. Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs. May 10, 2024. kff.org
- CMS. Medicare GLP-1 Bridge. Accessed September 14, 2026. cms.gov
- U.S. Food and Drug Administration. "FDA Proposes to Exclude Semaglutide, Tirzepatide, and Liraglutide on 503B Bulks List." April 30, 2026. fda.gov
- FDA. Human Drug Compounding. Current regulatory overview accessed September 15, 2026. fda.gov